PPARA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.895400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.538400E-01
Normal-vs-Stage2
8.578000E-01
Normal-vs-Stage3
3.179200E-01
Normal-vs-Stage4
9.984600E-01
Stage1-vs-Stage2
6.629200E-01
Stage1-vs-Stage3
1.993450E-01
Stage1-vs-Stage4
5.094800E-01
Stage2-vs-Stage3
2.355400E-01
Stage2-vs-Stage4
3.371800E-01
Stage3-vs-Stage4
2.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.437800E-01
Normal-vs-AfricanAmerican
2.670600E-01
Normal-vs-Asian
8.629200E-01
Caucasian-vs-AfricanAmerican
1.155810E-01
Caucasian-vs-Asian
9.022200E-01
AfricanAmerican-vs-Asian
1.463960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.135200E-01
Normal-vs-Female
8.633400E-01
Male-vs-Female
8.248800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.810800E-01
Normal-vs-Age(41-60Yrs)
6.980600E-01
Normal-vs-Age(61-80Yrs)
9.272000E-01
Normal-vs-Age(81-100Yrs)
5.981600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.722200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.534400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.084200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.360200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.264390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.521600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.001800E-01
Normal-vs-Daily Drinker
7.620400E-01
Normal-vs-Weekly Drinker
7.303600E-01
Normal-vs-Occasional Drinker
8.897200E-01
Normal-vs-Social Drinker
4.700200E-01
Non Drinker-vs-Daily Drinker
8.695200E-01
Non Drinker-vs-Weekly Drinker
2.642800E-01
Non Drinker-vs-Occasional Drinker
3.948400E-01
Non Drinker-vs-Social Drinker
2.231600E-02
Daily Drinker-vs-Weekly Drinker
2.471800E-01
Daily Drinker-vs-Occasional Drinker
4.074400E-01
Daily Drinker-vs-Social Drinker
7.852300E-02
Weekly Drinker-vs-Occasional Drinker
6.635800E-01
Weekly Drinker-vs-Social Drinker
7.150800E-01
Occasional Drinker-vs-Social Drinker
3.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.780600E-01
Normal-vs-Grade 2
6.319700E-02
Normal-vs-Grade 3
4.805800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.821000E-01
Grade 1-vs-Grade 3
6.680600E-01
Grade 1-vs-Grade 4
2.780600E-01
Grade 2-vs-Grade 3
8.579400E-01
Grade 2-vs-Grade 4
6.319700E-02
Grade 3-vs-Grade 4
4.805800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.973200E-01
Normal-vs-NonDiabetic
8.826200E-01
Diabetic-vs-NonDiabetic
2.095400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.680200E-01
Normal-vs-NoPancreatitis
9.778000E-01
Pancreatitis-vs-NoPancreatitis
4.824400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.396600E-01
Normal-vs-N1
8.445400E-01
N0-vs-N1
7.461400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.121400E-01
Normal-vs-TP53-NonMutant
5.441400E-01
TP53-Mutant-vs-TP53-NonMutant
4.137400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
